Evidence map›Paper›PMID 41585851›Full record

ArticleEndoscopic ultrasound

EUS-guided liver biopsy: A useful and cost-effective alternative for specific indications in the study of liver diseases.

Teresa Alvarez-Nava, Carolina Ibarrola, Felipe de la Morena, José Díaz-Tasende, Yolanda Rodríguez-Gil, Carlos de la Serna, Cristina Martin-Arriscado, Ana Martín, Inmaculada Fernández, Ángel Sánchez and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Teresa Alvarez-NavaGastroenterology Department, Biliopancreatic, Endoscopy and Hepatology Units, 12 de Octubre University Hospital, Madrid, Spain.
Carolina IbarrolaFaculty of Medicine, Complutense University, Madrid, Spain.
Felipe de la MorenaGastroenterology Department, University Hospital de la Princesa, Madrid, Spain.
José Díaz-TasendeGastroenterology Department, Biliopancreatic, Endoscopy and Hepatology Units, 12 de Octubre University Hospital, Madrid, Spain.
Yolanda Rodríguez-GilFaculty of Medicine, Complutense University, Madrid, Spain.
Carlos de la SernaGastroenterology Department, University Hospital Río Hortega, Valladolid, Spain.
Cristina Martin-ArriscadoScientific Support Unit, Research Institute (imas12), University Hospital 12 de Octubre, Madrid, Spain.
Ana MartínGastroenterology Department, Biliopancreatic, Endoscopy and Hepatology Units, 12 de Octubre University Hospital, Madrid, Spain.
Inmaculada FernándezGastroenterology Department, Biliopancreatic, Endoscopy and Hepatology Units, 12 de Octubre University Hospital, Madrid, Spain.
Ángel SánchezDepartment of Vascular Radiology, University Hospital 12 de Octubre, Madrid, Spain.
Mercedes Pérez-CarrerasGastroenterology Department, Biliopancreatic, Endoscopy and Hepatology Units, 12 de Octubre University Hospital, Madrid, Spain.ORCID https://orcid.org/0000-0001-7539-0005

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Comparative studies have demonstrated that EUS-guided liver biopsy (EUS-LB) is a useful and safe technique. However, there is not sufficient evidence information on their cost differences and potential applications. We aimed to investigate whether EUS-LB is a cost-effective alternative to traditional LB methods (percutaneous [PC-LB], transjugular [TJ-LB]) and determine its indications in clinical practice. Methods: In this observational, prospective, and multicenter study, patients who underwent EUS-LB at different tertiary centers ( Results: EUS-LB had 87% of diagnostic yield and 4% of mild adverse events, similar to traditional techniques ( Conclusions: EUS-LB is a useful alternative to traditional methods and the most cost-effective option when both LB and EUS are indicated, in cases of cholestasis as an alternative to MRCP and when the PC route is contraindicated.

Indexed as

Cost-efficacyEndohepatologyEUSEUS–guided liver biopsyHistological diagnosisLiver biopsyMetabolic dysfunction–associated steatotic liver disease

Identifiers

PMID41585851
PMCPMC12829719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.